Update on allergic fungal rhinosinusitis

AJ Chua, A Jafar, AU Luong - Annals of Allergy, Asthma & Immunology, 2023 - Elsevier
Allergic fungal rhinosinusitis (AFRS) is a unique clinical entity that falls under the broader
umbrella of chronic rhinosinusitis with nasal polyps with type 2 inflammation. It is …

[PDF][PDF] The different clinical presentations of allergic fungal rhinosinusitis

N Mulhem, A Al Momen, F Almolani - Otolaryngol Open Access J, 2018 - researchgate.net
The Different Clinical Presentations of Allergic Fungal Rhinosinusitis. Otolaryngol Open Access
J 2018, 3(2): 000172. Page 1 Otolaryngology Open Access Journal ISSN: 2476-2490 The …

Outcomes of dupilumab treatment versus endoscopic sinus surgery for chronic rhinosinusitis with nasal polyps

H Dharmarajan, O Falade, SE Lee… - International Forum of …, 2022 - Wiley Online Library
Abstract Background Outside of SINUS‐24 (A Controlled Clinical Study of Dupilumab in
Patients With Bilateral Nasal Polyps) and SINUS‐52 (Controlled Clinical Study of Dupilumab …

Allergic fungal rhinosinusitis

T Daniller - Current Allergy & Clinical Immunology, 2013 - journals.co.za
Allergic fungal rhinosinusitis is a distinct form of chronic rhinosinusitis characterised by the
formation of nasal polyps, accumulation of eosinophilic mucin and possible bony erosion …

Successful management of eosinophilic chronic rhinosinusitis complicated by severe asthma using dupilumab, following negative initial results with benralizumab

I Suzaki, A Tanaka, K Hirano, S Arai… - Allergology …, 2021 - jstage.jst.go.jp
Eosinophilic chronic rhinosinusitis (ECRS) is a subtype of refractory chronic rhinosinusitis
(CRS) characterized by ethmoidpredominant sinusitis with eosinophilic infiltration, and …

Optimal management of allergic fungal rhinosinusitis

G Medikeri, A Javer - Journal of Asthma and Allergy, 2020 - Taylor & Francis
Introduction Allergic fungal rhinosinusitis (AFRS) is a chronic disorder with significant
morbidity and a high recurrence rate needing long-term follow-up. Even after its first …

[PDF][PDF] Severe chronic rhinosinusitis treated with dupilumab, a real-life analysis of early effectiveness.

D Mocellin, A Ioppi, G Gaglio… - European Review for …, 2023 - europeanreview.org
OBJECTIVE: The present study evaluated the safety and efficacy of dupilumab in severe
uncontrolled type 2 chronic rhinosinusitis with nasal polyps (CRSwNP). PATIENTS AND …

[HTML][HTML] A prospective study on the efficacy of dupilumab in chronic rhinosinusitis with type 2 inflammation

M Trimarchi, A Vinciguerra, A Rampi… - Acta …, 2022 - ncbi.nlm.nih.gov
Objective Treatment for chronic rhinosinusitis with nasal polyps (CRSwNP) includes
endoscopic sinus surgery and topic and/or systemic corticosteroids, which have only …

Long-term efficacy of dupilumab for eosinophilic chronic rhinosinusitis

Y Tsunemi, T Nakayama, T Kashiwagi… - American Journal of …, 2024 - journals.sagepub.com
Background Eosinophilic chronic rhinosinusitis (eCRS) is a type 2 inflammatory disease that
frequently recurs after surgery. In recent years, dupilumab has been available for the …

Co-treatment with steroid and dupilumab for eosinophilic chronic rhinosinusitis after eosinophilic pneumonitis caused by Dupilumab

T Sudo, T Tsuda, M Hayama, K Takeda… - Ear, Nose & Throat …, 2022 - journals.sagepub.com
Eosinophilic chronic rhinosinusitis (ECRS) is a Type 2 inflammatory disease that manifests
as chronic inflammation of the paranasal sinus. IL-4/IL-13 receptor monoclonal antibodies …